Katrina Rice to present perspectives and examples of digitally-enabled data processes that accelerate clinical trial timelines
eClinical Solutions, a global provider of digital clinical software and services, today announced it will further bolster its role as a life sciences industry thought leader by presenting at the DIA 2022 Global Annual Meeting in Chicago this week. At the industry-renowned event, Katrina Rice, eClinical Solutions’ Chief Delivery Officer, Data Services, will chair and speak in DIA session #304 with Shelley Douros, Sr. Director of Product & Analytics, Clinical Financial Management at Medidata Solutions, titled “Transformation of the Data Manager to the Data Scientist”. The session, taking place on Wednesday, June 22 from 9-10 am CT in room 470 B, will consist of two supporting presentations: What the Future State Really Looks Like for Clinical Data Leaders, led by Rice; and How Data Scientists Bring Insights and Visibility to Clinical Trial Budgeting, led by Douros.
Today’s life sciences companies rely on their data management and operations teams to manage an enormous volume of data from next-generation clinical trials. Clinical data stakeholders don’t want to be bogged down with spreadsheets and caught up in time-consuming manual processes – they want to focus on meaningful work that will positively impact patients’ lives. In “Transformation of the Data Manager to the Data Scientist,” Rice and Douros will provide real-world examples of digitally-enabled data processes and how the shift toward data science is creating meaningful value – from control and insight into trial budgeting, to streamlining and reducing cycle times for data management.
“As clinical trials have evolved and the complexity has increased, we’ve seen the role of the clinical data professional transform in skillset and scope,” said Rice. “With life sciences organizations readily adopting decentralized and digital trial approaches, clinical data leaders have an opportunity to be the strategist and steward for this most critical asset of research. I look forward to joining the DIA community to discuss how data management and their collaborators can apply pandemic lessons learned to address the acceleration of the clinical data lifecycle.”
Additionally, the eClinical team will meet with attendees and conduct demos in booth #1707 to share how the elluminate Clinical Data Cloud provides life sciences organizations with data oversight, control, and efficiency to help bring treatments to patients faster. New additions to the platform will be showcased, including the integrated elluminate Statistical Computing Environment (SCE) and elluminate Sample Management Analytics. elluminate SCE is a validated environment that streamlines the production of submission or exploratory analysis outputs with one centralized place for all data, metadata, programs, and results. elluminate Sample Management Analytics automates manual sample tracking processes for proactive oversight and real-time sample management.
As the foundation for digital trials, the elluminate platform provides a central location for all clinical and operational data, creating a single source of truth across all data sources from ingestion to insights. The platform’s out of the box data connectors, built-in automation, advanced analytics, and self-service access to data from a single location allow value to be recognized faster and enable smarter decision-making throughout the trial lifecycle for top 20, mid-size, and emerging life science companies.
For more information on eClinical Solutions’ presence at DIA please visit: https://www.eclinicalsol.com/event/dia-2022-global-annual-meeting/.
For more such updates and perspectives around Digital Innovation, IoT, Data Infrastructure, AI & Cybersecurity, go to AI-Techpark.com.
